- Home
- RGNX vs MMD Comparison
RGNX vs MMD Comparison
Compare RGNX & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- MMD
- Stock Information
- Founded
- RGNX 2008
- MMD 2012
- Country
- RGNX United States
- MMD United States
- Employees
- RGNX N/A
- MMD N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- MMD Investment Managers
- Sector
- RGNX Health Care
- MMD Finance
- Exchange
- RGNX Nasdaq
- MMD Nasdaq
- Market Cap
- RGNX 459.1M
- MMD 439.8M
- IPO Year
- RGNX 2015
- MMD N/A
- Fundamental
- Price
- RGNX $7.62
- MMD $14.85
- Analyst Decision
- RGNX Strong Buy
- MMD
- Analyst Count
- RGNX 12
- MMD 0
- Target Price
- RGNX $36.00
- MMD N/A
- AVG Volume (30 Days)
- RGNX 1.7M
- MMD 74.7K
- Earning Date
- RGNX 11-06-2024
- MMD 01-01-0001
- Dividend Yield
- RGNX N/A
- MMD 4.88%
- EPS Growth
- RGNX N/A
- MMD N/A
- EPS
- RGNX N/A
- MMD N/A
- Revenue
- RGNX $84,327,000.00
- MMD N/A
- Revenue This Year
- RGNX $2.34
- MMD N/A
- Revenue Next Year
- RGNX $243.67
- MMD N/A
- P/E Ratio
- RGNX N/A
- MMD N/A
- Revenue Growth
- RGNX N/A
- MMD N/A
- 52 Week Low
- RGNX $7.21
- MMD $14.30
- 52 Week High
- RGNX $28.80
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- RGNX 36.08
- MMD 23.02
- Support Level
- RGNX $8.06
- MMD $15.60
- Resistance Level
- RGNX $10.52
- MMD $15.46
- Average True Range (ATR)
- RGNX 0.76
- MMD 0.27
- MACD
- RGNX -0.19
- MMD -0.08
- Stochastic Oscillator
- RGNX 12.39
- MMD 1.37
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
MainStay MacKay DefinedTerm Municipal Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company may also invest in TOB (Tender Option Bonds) Floaters and TOB Residuals issued by the TOB Issuer. It evaluates its performance against Barclays Municipal Bond Index.